publication date: Sep. 18, 2020
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.
This January, the American Cancer Society reported the sharpest drop in U.S. cancer mortality ever recorded. Between 2016 and 2017, the death rate from cancer fell 2.2%, continuing the trajectory of a 29% decline in cancer mortality since 1991.
The unprecedented COVID-19 pandemic makes it possible to compare and contrast the public health and political responses to previous health crises.
As of September, more than 270,000 deaths have been confirmed in Latin American countries due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
On Jan. 6, Barry P. Sleckman’s started his job as director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.
The American Association of Cancer Research Sept. 16 published a comprehensive report on disparities in cancer, describing in deep detail the outsized toll that cancer exacts on racial and ethnic minorities and other underserved populations.
NIH Director Francis S. Collins said he expects at least one of the vaccines against COVID-19 to be proven safe and effective by the end of 2020.
- Emily Tonorezos named head of NCI’s Office of Cancer Survivorship
- Electra Paskett named director of the Alliance Cancer Control Program and PI for the Alliance NCORP Research Base
- ACCC announces 2020 Innovator Award winners
- NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
- Lois Travis awarded $5.7 million from NCI to study chemo-induced hearing loss, toxicities
- Katz, An, Kurian awarded $3.7 million in Moonshot funds to address genetic testing among families
- YCC receives $1.2 million NIH grant to fund gene imaging research
- YCC receives $175k research grant from Breast Cancer Research Foundation
- Five researchers receive shared $9 million grant from Aligning Science Across Parkinson’s initiative
Navigating a cancer diagnosis is difficult, and even more so during a global pandemic.
- Korean study examines the combined impact of aspirin, metformin, and statin’s impact on lung cancer risk
- Cigarette smoking associated with worse outcomes for bladder cancer patients after surgery
- Partner Therapeutics begins phase III study of leukine + ipilumimab and nivolumab front-line melanoma
- Despite progress, adolescents and young adults face substantial cancer disparities by race/ethnicity
- Study: Rubbery properties help RNA nanoparticles target tumors efficiently and quickly leave body
- Rhenium NanoLiposomes receives Fast Track Designation from FDA for glioblastoma treatment
- Elicio Therapeutics and Moffitt collaborate to study AMP-CD19 + CD19 CAR T cells
- UCSD, Cofactor Genomics collaborate to improve patient outcomes in metastatic head and neck cancer